| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.494 | 34.147 | 34.082 | 38.962 | 57.541 | 70.144 | 72.449 | 71.865 | 99.950 | 111.651 |
| Total Income - EUR | 32.495 | 35.150 | 34.083 | 38.963 | 57.542 | 73.866 | 78.827 | 71.866 | 99.952 | 111.655 |
| Total Expenses - EUR | 18.930 | 17.192 | 16.622 | 19.206 | 30.796 | 45.162 | 49.568 | 51.251 | 52.597 | 69.304 |
| Gross Profit/Loss - EUR | 13.565 | 17.958 | 17.461 | 19.757 | 26.747 | 28.704 | 29.259 | 20.615 | 47.355 | 42.350 |
| Net Profit/Loss - EUR | 12.590 | 17.607 | 16.875 | 19.367 | 26.173 | 28.244 | 28.550 | 19.975 | 46.506 | 39.503 |
| Employees | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Biomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.652 | 8.951 | 7.357 | 10.854 | 8.528 | 6.650 | 17.200 | 15.120 | 13.497 | 31.692 |
| Current Assets | 22.453 | 22.334 | 18.551 | 14.429 | 23.113 | 30.034 | 16.411 | 26.784 | 62.305 | 63.735 |
| Inventories | 74 | 99 | 152 | 161 | 203 | 171 | 167 | 156 | 155 | 72 |
| Receivables | 1.598 | 2.780 | 3.017 | 2.901 | 4.058 | 3.688 | 4.395 | 13.897 | 36.790 | 26.356 |
| Cash | 20.781 | 19.456 | 15.382 | 11.368 | 18.852 | 26.175 | 11.849 | 12.732 | 25.360 | 37.307 |
| Shareholders Funds | 21.885 | 24.594 | 23.759 | 23.995 | 28.630 | 30.695 | 31.072 | 22.755 | 50.997 | 52.823 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.311 | 6.736 | 2.148 | 1.288 | 3.011 | 5.988 | 2.539 | 19.150 | 24.804 | 42.604 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Biomed Srl